PRESS RELEASE published on 02/17/2026 at 07:30, 5 months 14 days ago Inside Information / Other news releases Sensorion announces Nawal Ouzren stepping down as CEO for personal reasons. Amit Munshi to serve as Interim CEO. Sanofi-led financing for pipeline assets Leadership Changes Sanofi Sensorion Amit Munshi Nawal Ouzren
BRIEF published on 02/06/2026 at 07:35, 5 months 25 days ago Sensorion participera à la 49e réunion annuelle d'hiver de l'ARO. Biotechnologie Thérapie Génique Sensorion Perte Auditive Réunion ARO
BRIEF published on 02/06/2026 at 07:35, 5 months 25 days ago Sensorion to Participate in ARO 49th Annual Midwinter Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ARO Meeting
PRESS RELEASE published on 02/06/2026 at 07:30, 5 months 25 days ago Informations privilégiées / Autres communiqués Sensorion participe à la 49ème rencontre annuelle de l’ARO pour présenter sa nouvelle thérapie génique SENS-601 pour la surdité autosomique récessive non syndromique 1A Thérapie Génique Sensorion Perte Auditive Surdité ARO
PRESS RELEASE published on 02/06/2026 at 07:30, 5 months 25 days ago Inside Information / Other news releases Sensorion to present SENS-601 gene therapy at ARO 49th Annual Midwinter Meeting in Puerto Rico Gene Therapy Sensorion Hearing Loss SENS-601 ARO 49th Annual Midwinter Meeting
BRIEF published on 01/28/2026 at 07:48, 6 months 6 days ago Sensorion Secures €60 Million Financing to Advance Hearing Loss Therapies Gene Therapy Biotech Financing Sensorion Hearing Loss Sanofi Investment
BRIEF published on 01/28/2026 at 07:48, 6 months 6 days ago Sensorion obtient un financement de 60 millions d'euros pour faire progresser les thérapies contre la perte auditive Thérapie Génique Sensorion Perte Auditive Financement Des Biotechnologies Investissements Sanofi
PRESS RELEASE published on 01/28/2026 at 07:43, 6 months 6 days ago Informations privilégiées / Autres communiqués Sensorion annonce un financement de 60 millions d’euros avec Sanofi et d'autres investisseurs pour développer ses thérapies géniques. Trésorerie prévue jusqu'à mi-2027 Financement Trésorerie Thérapie Génique Sanofi Sensorion
PRESS RELEASE published on 01/28/2026 at 07:43, 6 months 6 days ago Inside Information / Other news releases Sensorion announces €60 million financing with a €20M strategic investment from Sanofi and support from global healthcare specialists to advance genetic medicine pipeline. Cash runway extended until H1 2027 Financing Sanofi Sensorion Genetic Medicine Healthcare Specialists
BRIEF published on 12/19/2025 at 07:35, 7 months 15 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
Published on 08/01/2026 at 01:58, 2 days 7 hours ago Clôture de l'option sur la propriété de graphite au Québec
Published on 08/01/2026 at 01:20, 2 days 8 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 8 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 9 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/03/2026 at 09:18, 30 minutes ago Conference call on the results for the 3rd quarter 2025/2026 (ending 30 June 2026) on 12 August 2026
Published on 08/03/2026 at 09:00, 49 minutes ago Invitation to the Half-Year Results Presentation 2026 on 10 August 2026
Published on 08/03/2026 at 08:29, 1 hour 20 minutes ago Launch of a €225 million tranche of its share buyback programme
Published on 08/03/2026 at 08:29, 1 hour 20 minutes ago Lancement d’une tranche de 225 millions d’euros du programme de rachat d’actions
Published on 08/03/2026 at 07:00, 2 hours 49 minutes ago BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 08/03/2026 at 07:00, 2 hours 49 minutes ago Biophytis fait un point d’étape et partage les perspectives de sa co-entreprise à Hong Kong
Published on 07/31/2026 at 21:00, 2 days 12 hours ago Carrefour finalise la vente de sa participation minoritaire dans CarrefourSA en Turquie à Yeni Mağazacılık A.Ş., société opérant l'enseigne de A101 et contrôlée par le Groupe Aydın
